CCXI (ChemoCentryx) IPO’s at $10/sh: http://www.reuters.com/article/2012/02/08/chemocentryx-idUSL4E8D877F20120208 The original has been an IPO in the $14-16 range. GSK is a CCXI shareholder and also a licensee (#msg-70579127).